The Grammy-winning superstar took to Instagram with a little something for the haters alleging she’s on Ozempic. In a side-by ...

Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular class of weight-loss and diabetes drugs that include Ozempic ...

A new study adds to mounting evidence showing that drugs like Ozempic don’t just treat diabetes — they can also prevent it. The new paper, published Wednesday in The New England Journal of ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday. CNN values your feedback 1.

Fat Joe memes mock the widely panned performance by the rapper at game three of the World Series at Yankee Stadium on Monday. Potentially as a follow-up to Ice Cube’s appearance at the Dodgers ...

Ozempic has been approved only for type 2 diabetics, and Wegovy has been approved only for patients with a BMI above 30, or 27 if they have a weight-related comorbidity like high blood pressure.

Popular weight-loss and diabetes drugs, including Ozempic and Zepbound, may be connected to rare eye conditions that could lead to vision loss, according to a new study published in JAMA ...

Ozempic and Wegovy may reduce alcohol cravings, some users say 04:45. Patients who take drugs like Wegovy or Ozempic for weight loss may notice another side effect, according to some users ...

The term "Ozempic face" is not a medical term, but some use it to describe this type of appearance after weight loss. Here what's fact and fiction.

Cheri Ferguson has traded her vape pen for an Ozempic pen. One day seven weeks ago, “I thought, ‘you’re doing something about your weight; leave your vape at home,’ ” Ferguson said. She ...

Ozempic, a drug used to treat type two diabetes, has gained enormous popularity due to its off-label use for weight loss in those that do not have diabetes. On TikTok alone, the #ozempic has ...

Ozempic Might Help You Drink and Smoke Less Animal studies suggest GLP-1 drugs alter behaviors associated with reward and pleasure Michael McCluskey, of Nova Scotia, Canada, has been taking ...